Regenerative Medicine · 2011 · 84 citations · 221 references
Life SciencesCell BiologyHematologyRegenerative MedicineStem Cell BiologyStem Cell TransplantationCell EngraftmentGraft SurvivalHematopoietic Stem Cell TransplantationHematopoietic Stem CellsImmunomodulation In RegenerationTissue Engineering With Stem CellsAnimal Disease ModelsCellular Reconstitution AssessmentClinical Safety EvaluationGraftingNeural Cell EngraftmentNeural Stem Cell TransplantationStem Cell ResponsesStem Cell Transplantation Models
There is potential for a variety of stem cell populations to mediate repair in the diseased or injured CNS; in some cases, this theoretical possibility has already transitioned to clinical safety testing. However, careful consideration of preclinical animal models is essential to provide an appropriate assessment of stem cell safety and efficacy, as well as the basic biological mechanisms of stem cell action. This article examines the lessons learned from early tissue, organ and hematopoietic grafting, the early assumptions of the stem cell and CNS fields with regard to immunoprivilege, and the history of success in stem cell transplantation into the CNS. Finally, we discuss strategies in the selection of animal models to maximize the predictive validity of preclinical safety and efficacy studies.
221
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki et al. · Cell · 2007 · 20.2K citations
Embryonic Stem Cell Lines Derived from Human Blastocysts
James A. Thomson, Joseph Itskovitz‐Eldor, Sander S. Shapiro et al. · Science · 1998 · 15.9K citations
The Medical Journal of Australia · 1999 · 3.4K citations
RAG-1-deficient mice have no mature B and T lymphocytes
Peter Mombaerts, John Iacomini, Randall S. Johnson et al. · Cell · 1992 · 2.9K citations
Life Sciences, Genetics, Immunology +13